2024
- Gilles M, Baybekov S, Llompart P, Gizzi P, Galzi JL, Ramos P, Saurel O, Bourban C, Minoletti C, Varnek A. Kinetic solubility: experimental and machine-learning modeling perspectives. Mol Inform. 2023 Dec 27. doi: 10.1002/minf.202300216
Kuntzel T, Spenlé C, Pham-Van LD, Birmpili D, Riou A, Loeuillet A, Charmarke-Askar I, Bagnard D. Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation. Cells. 2023 May 10;12(10):1361. doi: 10.3390/cells12101361
Lehot V, Neuberg P, Ripoll M, Daubeuf F, Erb S, Dovgan I, Ursuegui S, Cianférani S, Kichler A, Chaubet G, Wagner A. Targeted Anticancer Agent with Original Mode of Action Prepared by Supramolecular Assembly of Antibody Oligonucleotide Conjugates and Cationic Nanoparticles. Pharmaceutics. 2023 Jun 2;15(6):1643. doi: 0.3390/pharmaceutics15061643
Leroy C, Spelier S, Essonghe NC, Poix V, Kong R, Gizzi P, Bourban C, Amand S, Bailly C, Guilbert R, Hannebique D, Persoons P, Arhant G, Prévotat A, Reix P, Hubert D, Gérardin M, Chamaillard M, Prevarskaya N, Rebuffat S, Shapovalov G, Beekman J, Lejeune F. Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis. Mol Ther. 2023 Apr 5;31(4):970-985. doi: 10.1016/j.ymthe.2023.01.014
Zeder-Lutz G, Bornert O, Fellmann-Clauss R, Knittel Obrecht A, Tranchant T, Bouteben S, Kaeffer J, Quillet R, Villa P, Wagner R, Lecat L and Simonin F. Characterization of anti-GASP motif antibodies that inhibit the interaction between GPRASP1 and G protein-coupled receptors. Analytical Biochemistry (2023) vol 665 March 2023. doi.org/10.1016/j.ab.2023.115071.
Eguida M., Schmitt-Valencia C., Hibert M., Villa P., Rognan D. Target-focused library design by pocket-applied computer vision and fragment deep generative linking. J. Med. Chem. 2022, 65, 13771-83. Doi :10.1021/acs.jmedchem.2c00931
Rady T, Turelli L, Nothisen M, Tobaldi E, Erb S, Thoreau F, Hernandez-Alba O, Cianferani S, Daubeuf F, Wagner A, Chaubet G. A Novel Family of Acid-Cleavable Linker Based on Cyclic Acetal Motifs for the Production of Antibody-Drug Conjugates with High Potency and Selectivity. Bioconjug Chem. 2022 Sep 15. doi: 10.1021/acs.bioconjchem.2c00314
Pierrevelcin M, Flacher V, Mueller CG, Vauchelles R, Guerin E, Lhermitte B, Pencreach E, Reisch A, Muller Q, Doumard L, Boufenghour W, Klymchenko AS, Foppolo S, Nazon C, Weingertner N, Martin S, Briandet C, Laithier V, Di Marco A, Bund L, Obrecht A, Villa P, Dontenwill M, Entz-Werlé N. Engineering Novel 3D Models to Recreate High-Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment. Adv Healthc Mater. 2022 Sep 4:e2200195. doi: 10.1002/adhm.202200195
Segaud J, Yao W, Marschall P, Daubeuf F, Lehalle C, German B, Meyer P, Hener P, Hugel C, Flatter E, Guivarch M, Clauss L, Martin SF, Oulad-Abdelghani M, Li M. Context-dependent function of TSLP and IL-1β in skin allergic sensitization and atopic march. Nat Commun. 2022 Sep 1;13(1):4703. doi: 10.1038/s41467-022-32196-1
Poirot A, Wacht G, Lehalle C, Saas P, Frossard N, Geny B, de Blay F, Barnig C; NK cells and lipoxin A4 promote resolution of eosinophilic inflammation after nasal allergen challenge; Allergy. (2022) Jan;77(1):309-313; doi: 10.1111/all.15103
Schall N, Daubeuf F, Marsol C, Gizzi P, Frossard N, Bonnet D, Galzi JL, Muller S. A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone Mice. Front Pharmacol. 2021 Oct 21;12:752194. doi: 10.3389/fphar.2021.752194. eCollection 2021.